Details of the Drug
General Information of Drug (ID: DMGPQ0Y)
Drug Name |
T-1105
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3-Hydroxypyrazine-2-carboxamide; 55321-99-8; 2-oxo-1H-pyrazine-3-carboxamide; 3-Oxo-3,4-dihydropyrazine-2-carboxamide; Pyrazinecarboxamide, 3,4-dihydro-3-oxo-; NSC163503; SZPBAPFUXAADQV-UHFFFAOYSA-N; Pyrazine-2-carboxamide, 3-hydroxy-; t6mv dnj cvz[wln]; 3-HYDROXYPYRAZINE-2-CARBOXAMINE; AC1Q6FTJ; AC1L6MD7; KSC273I6F; SCHEMBL1338425; ZINC8657; 3-Hydroxy-2-pyrazinecarboxamide; CTK1H3462; DTXSID10203888; 3-hydroxy-pyrazine-2-carboxamide; MolPort-005-980-549; 3-Hydroxy-2-pyrazinecarboxamide #
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 139.11 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -0.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||